Theravance Biopharma, Inc. 4
4 · Theravance Biopharma, Inc. · Filed Aug 18, 2015
Insider Transaction Report
Form 4
MALKIEL BURTON G
Director
Transactions
- Purchase
Ordinary Shares
2015-08-18$12.92/sh+10,000$129,200→ 20,571 total
Footnotes (1)
- [F1]Represents the weighted average purchase price per share for the open market purchase on August 18, 2015. The shares were purchased at prices ranging from $12.75 to $12.99 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.